Trial set for Gilead HIV antitrust claims case

Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Big Pharma

Gilead defeats US govt in billion-dollar HIV drug patent suit

11 May 2023 Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.

Big Pharma

US govt seeks new trial in Gilead HIV drug patent case

18 May 2023 The government lost its high stakes and unusual royalties dispute with the big pharma firm | New status report claims that the court should have allowed the jury to take four inter partes petitions into account.

More on this story

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Big Pharma

Gilead defeats US govt in billion-dollar HIV drug patent suit

11 May 2023 Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.

Big Pharma

US govt seeks new trial in Gilead HIV drug patent case

More on this story

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Big Pharma

Gilead defeats US govt in billion-dollar HIV drug patent suit

11 May 2023 Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.

Big Pharma

US govt seeks new trial in Gilead HIV drug patent case